CVS Caremark to cover Zepbound again after lawsuit, widespread backlash

CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.

Vanessa Trump reveals breast cancer diagnosis

Vanessa Trump revealed Wednesday that she has been diagnosed with breast cancer and has started a treatment plan.

Texas Children's Hospital must build 'detransition clinic' after $10M settlement

Texas Children's Hospital is required to construct a "detransition clinic" as part of a $10 million settlement with the state and the Department of Justice.

California’s $1.3B Medicaid funding put on hold amid fraud suspicions

The Trump administration is widening its initiative to eliminate fraud in the federal health program, which includes a $1.3 billion deferral of Medicaid funding to California.

Amazon stocking Ozempic pills at kiosks, offering same-day delivery

Amazon is making Ozempic pills more accessible and stocking its U.S. kiosks with the medication and offering same-day delivery.

White House says Trump's drugmaker deals could save economy $529B over next decade

President Trump’s “most favored nation” drugmaker deals could save the economy $529 billion over the next decade, a new White House analysis estimates.

Supreme Court restores abortion pill access

The Supreme Court has restored broad access to the abortion pill mifepristone.

Trump says GLP-1 weight-loss drugs coming at $50 for Medicare patients

President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a cost of only $50 per month.

$60M in federal funds approved for Texas rural hospital improvements

The Texas Health and Human Services Commission (HHSC) is making $60 million in initial federal funding available to rural hospital districts, the governor announced Thursday.

AI shaping our health care decisions, even whether we go to the doctor

For nearly half of Americans, artificial intelligence plays some sort of role in their health care decisions, a new Gallup poll found. 

Memorial Hermann says agreement has been made with Blue Cross Blue Shield

Memorial Hermann's facilities and physicians are once again in-network with Blue Cross Blue Shield of Texas, the health care system said Saturday.

FDA approves Foundayo, Eli Lilly's new GLP-1 obesity pill

The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold as Foundayo.